Entity

Time filter

Source Type

Okazaki, Japan

Provided is a hair-treatment composition containing an amphoteric surfactant having a structure represented by general formula (1) below, and a sugar nonionic surfactant. In general formula (1), R


Patent
Hoyu Co. | Date: 2013-06-20

A double-aerosol device including: inner containers that separately store a plurality of types of hair treatment compositions used by mixing as hair dye, a decoloring agent, or dye remover; and an outer container in which a plurality of inner containers are stored; in which the hair treatment compositions are discharged to the outside by contracting the inner containers by a pressure of propellant, the outer container is configured such that at least a part of the inside of the outer container is visible so as to confirm remaining amounts of the hair treatment compositions, and the inner containers store the hair treatment compositions in pouches.


Provided is a hair-treatment composition containing: a first amphoteric surfactant having a structure represented by general formula (1) below; at least one type of second amphoteric surfactant selected from the group consisting of fatty acid amide propyldimethylaminoacetic acid betaines, alkyldimethylaminoacetic acid betaines, N-acylaminoethyl-N-2-hydroxyethylaminocarboxylic acid salts and N-acylaminoethyl-N-carboxymethoxyethylaminocarboxylic acid salts fatty acid amide propyldimethylaminoacetic acid betaines, alkyldimethylaminoacetic acid betaines; and an acidic amino acid. In general formula (1), R


Patent
Hoyu Co. | Date: 2010-05-28

A hair cosmetic composition used for dyeing, bleaching, or destaining hair contains amino-modified silicone, dimethicone, and polyethylene glycol having a number average molecular weight of 10,000 or more.


Provided are a nerve growth inhibitor and a cutaneous-sensory-irritation inhibitor, with which dermal hyperesthesia and nerve extension based on newly found nerve extension mechanisms can be effectively inhibited. This nerve growth inhibitor or cutaneous-sensory-irritation inhibitor comprises one or more selected from: (1) a specific flavonoid; (2) a tannin; (3) chlorogenic acid; (4) a specific stilbenoid; and a glycoside or a pharmaceutically acceptable salt of (1)-(4); or (5) a specific crude drug extract; and (6) a walnut polyphenol.

Discover hidden collaborations